John Raymond Lawrence

What was reported

$16,747.58

in general payments reported to CMS, 2019-2025 · $4,802 in 2025

The $4,802 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).

Who reported paying

General payments only, top 6 by amount.

• Edwards Lifesciences Corporation $5,782.88
• Medtronic, INC. $4,529.34
• Abbott Laboratories $4,017.10
• Abiomed $653.86
• Boston Scientific Corporation $271.34
• Novartis Pharmaceuticals Corporation $240.66

Drugs and devices associated with these payments

Edwards Sapien 3 Transcatheter Heart Valve (Thv) Corevalve Evolut R Triclip Mitraclip Sapien 3 Ultra Resilia Impella Evoque Amplatzer Amulet Gore Cardioform Septal Occluder Leqvio Lifevest Watchman Flx

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

• I saw John Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?
• Is there a generic or alternative to this medication, and would it work as well for me?
• What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.